Skip to main content
Top
Published in: Lung 3/2007

01-05-2007 | Brief Report

Sjögren’s Syndrome with Multiple Bullae Caused by Lymphocytic Interstitial Pneumonia

Authors: Hirokazu Tokuyasu, Etsuko Watanabe, Ryota Okazaki, Yuji Kawasaki, Ryutaro Kikuchi, Noritaka Isowa, Hideyuki Ohnuma, Hiroshi Miura, Eiji Shimizu, Yoichiro Kobashi

Published in: Lung | Issue 3/2007

Login to get access

Excerpt

The mechanism of parenchymal bulla formation is poorly understood. It has been postulated that the mechanism of bullae formation probably involves inflammatory cell infiltration into the bronchial wall, resulting in narrowing of the airways. Thus, cell infiltration acts as a check valve mechanism [1]. Although several pulmonary disorders have been described in patients with Sjögren’s syndrome, cystic or bullous lung disease is rare [2]. Because our patient was of child-bearing age and a nonsmoker, we needed to determine whether the bullae was associated with Sjögren’s syndrome or caused by lymphangioleiomyomatosis (LAM). The bullae that are characteristic of LAM are 5–15 mm in diameter, have thin walls, and are homogeneously distributed in all lung fields [3]. In the present case, however, the bullae formation was predominant in the middle and lower lung zones (Fig. 1). Furthermore, the walls of the bullae were irregular and their sizes varied from 5 to 60 mm in diameter. Consequently, the bullae in patients with Sjögren’s syndrome differ from those in patients with LAM. Although a rare occurrence, it is imperative to consider that multiple bullous formation can be associated with Sjögren’s syndrome.
Literature
1.
go back to reference Kobayashi H, Matsuoka R, Kitamura S, Tunoda N, Saito K (1988) Sjögren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 94:438–440PubMed Kobayashi H, Matsuoka R, Kitamura S, Tunoda N, Saito K (1988) Sjögren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 94:438–440PubMed
2.
go back to reference Moutsopoulos HM, Chused TM, Mann DL, et al. (1980) Sjögren’s syndorome (Sicca syndrome): current issues. Ann Intern Med 92:212–226PubMed Moutsopoulos HM, Chused TM, Mann DL, et al. (1980) Sjögren’s syndorome (Sicca syndrome): current issues. Ann Intern Med 92:212–226PubMed
3.
go back to reference Taylor JR, Ryu J, Colby TV, Raffin TA (1990) Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 323:1254–1260 Taylor JR, Ryu J, Colby TV, Raffin TA (1990) Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 323:1254–1260
Metadata
Title
Sjögren’s Syndrome with Multiple Bullae Caused by Lymphocytic Interstitial Pneumonia
Authors
Hirokazu Tokuyasu
Etsuko Watanabe
Ryota Okazaki
Yuji Kawasaki
Ryutaro Kikuchi
Noritaka Isowa
Hideyuki Ohnuma
Hiroshi Miura
Eiji Shimizu
Yoichiro Kobashi
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Lung / Issue 3/2007
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-007-9002-5

Other articles of this Issue 3/2007

Lung 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine